H.C. Starck has appointed Dr Dennis Schulze to serve as a member of the Executive Board and Chief Financial Officer of the H.C. Starck Group. Dr Engelbert Heimes will remain Chairman of the Executive Board of the Group on an ongoing basis. Schulze will replace Dr Matthias Schmitz, who is leaving the company to take on a new professional role.
Additionally, Dr Jan Lösch has been newly appointed to the Executive Management of H.C. Starck GmbH where he will serve as Managing Director responsible for Accounting and Controlling. Dr Jens Knöll will assume the position of the Chairman of the Executive Management of H.C. Starck GmbH in addition to his duties as Chief Operating Officer of H.C. Starck Group. Dr Michael Reiß remains member of the Executive Management of H.C. Starck GmbH.
Schmitz had informed the Supervisory Board of his decision not to extend his contract which was due end of 2016 and pursue opportunities outside the Group. He joined H.C. Starck Group in July 2014 as Member of the Executive Board and Financial Director. During this time, Schmitz made substantial contributions to the company’s further development, including the Group’s successful refinancing. “We sincerely thank Matthias Schmitz for all his hard work and dedication to the H.C. Starck Group. Amongst other, Mr. Schmitz played a crucial role in last year’s successful refinancing,” stated Engelbert Heimes, Chairman of the Executive Board of the H.C. Starck Group.
Dennis Schulze served as Chief Financial Officer of Douglas Group from 2013 until 2016. Between 1999 and 2012, he worked at The Carlyle Group, most recently as a Managing Director in Germany. “We look forward to working with Dennis Schulze. His broad experience in Private Equity and financing will be a great asset to the further development of the H.C. Starck Group, which he is already familiar with from his time at Carlyle,” added Engelbert Heimes.